Cargando…
Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines
The development of new and effective adjuvants may play a fundamental role in improving HIV vaccine efficacy. New classes of vaccine adjuvants activate innate immunity receptors, notably toll like receptors (TLRs). Adjuvants targeting the C-Type lectin receptor DC-SIGN may be alternative or compleme...
Autores principales: | Berzi, Angela, Varga, Norbert, Sattin, Sara, Antonazzo, Patrizio, Biasin, Mara, Cetin, Irene, Trabattoni, Daria, Bernardi, Anna, Clerici, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939462/ https://www.ncbi.nlm.nih.gov/pubmed/24473338 http://dx.doi.org/10.3390/v6020391 |
Ejemplares similares
-
Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants
por: Berzi, Angela, et al.
Publicado: (2016) -
New Insights in the Fight against HIV
por: Trabattoni, Daria, et al.
Publicado: (2021) -
Enhancing Potency and Selectivity of a DC‐SIGN Glycomimetic Ligand by Fragment‐Based Design: Structural Basis
por: Medve, Laura, et al.
Publicado: (2019) -
Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists
por: Obermajer, Nataša, et al.
Publicado: (2010) -
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
por: Valle-Argos, Beatriz, et al.
Publicado: (2021)